Childhood cancer: occurrence, treatment and risk of second primary malignancies

S Zahnreich, H Schmidberger - Cancers, 2021 - mdpi.com
Simple Summary Childhood cancers are mostly of unknown etiology and represent
devastating diagnoses. The clinical benefits of steadily increasing tumor control and survival …

Current state of immunotherapy and mechanisms of immune evasion in ewing sarcoma and osteosarcoma

V Evdokimova, H Gassmann, L Radvanyi… - Cancers, 2022 - mdpi.com
Simple Summary Pediatric sarcomas, including Ewing sarcoma and osteosarcoma, were
first to be treated with an anticancer vaccine 100 years ago. This review moves on from a …

High-dose treosulfan and melphalan as consolidation therapy versus standard therapy for high-risk (metastatic) Ewing sarcoma

R Koch, H Gelderblom, L Haveman… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE Ewing 2008R3 was conducted in 12 countries and evaluated the effect of
treosulfan and melphalan high-dose chemotherapy (TreoMel-HDT) followed by reinfusion of …

Surgical treatment of bone sarcoma

F Bläsius, H Delbrück, F Hildebrand, UK Hofmann - Cancers, 2022 - mdpi.com
Simple Summary Even today, a malignant bone tumor is still a threatening condition for the
patient. Such tumors are difficult to treat and they require an interdisciplinary approach to …

Evolution-informed strategies for combating drug resistance in cancer

K Lin-Rahardja, DT Weaver, JA Scarborough… - International Journal of …, 2023 - mdpi.com
The ever-changing nature of cancer poses the most difficult challenge oncologists face
today. Cancer's remarkable adaptability has inspired many to work toward understanding …

The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: A review

AA Apfelbaum, ED Wrenn, ER Lawlor - Frontiers in oncology, 2022 - frontiersin.org
Accumulating evidence shows that despite clonal origins tumors eventually become
complex communities comprised of phenotypically distinct cell subpopulations. This …

The expression changes of PD-L1 and immune response mediators are related to the severity of primary bone tumors

AR Eghtedari, MA Vaezi, E Safari, V Salimi… - Scientific Reports, 2023 - nature.com
The expression pattern, diagnostic value, and association of PD-L1, IFN-γがんま and TGF-βべーた with
bone tumor type, severity, and relapse are determined in this study. 300 human samples …

A bifunctional PARP-HDAC inhibitor with activity in ewing sarcoma

L Ramos, S Truong, B Zhai, J Joshi, F Ghaidi… - Clinical Cancer …, 2023 - AACR
Purpose: Histone deacetylase (HDAC) inhibition has been shown to induce pharmacologic
“BRCAness” in cancer cells with proficient DNA repair activity. This provides a rationale for …

The oncolytic adenovirus XVir-N-31 joins forces with CDK4/6 inhibition augmenting innate and adaptive antitumor immunity in Ewing sarcoma

SJ Schober, C Schoening, J Eck, C Middendorf… - Clinical Cancer …, 2023 - AACR
Abstract Purpose: Ewing sarcoma (EwS) is a highly malignant pediatric tumor characterized
by a non-T-cell-inflamed immune-evasive phenotype. When relapsed or metastasized …

Current insights into the role of Fli-1 in hematopoiesis and malignant transformation

Y Ben-David, B Gajendran, KM Sample… - Cellular and Molecular …, 2022 - Springer
Fli-1, a member of the ETS family of transcription factors, was discovered in 1991 through
retroviral insertional mutagenesis as a driver of mouse erythroleukemias. In the past 30 …